Retour
Fourchette du Jour
13,68 €
14,11 €
Fourchette 52 Semaines
4,97 €
17,09 €
Volume
2 263 417
Moyenne 50J / 200J
14,28 €
/
9,99 €
Clôture Précédente
13,89 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -12,6 | 0,4 |
| P/B | — | 2,9 |
| ROE % | -313,3 | 3,7 |
| Net Margin % | -8,4 | 3,9 |
| Rev Growth 5Y % | 3,3 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
17,50 €
+25.4%
Low: 17,00 €
High: 18,00 €
BPA Prévisionnel
-0,23 €
CA Est.
3 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,05 €
0,05 € – 0,05 €
|
3,1 B | 2 |
| FY2026 |
-0,23 €
-0,23 € – -0,23 €
|
3 B | 2 |
Points Clés
Revenue grew 3,29% annually over 5 years — modest growth
Negative free cash flow of -294,52M
ROIC of 0,19% — low return on invested capital
Interest coverage of 0,07× — tight debt servicing
Croissance
Revenue Growth (5Y)
3,29%
Revenue (1Y)4,77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-313,25%
ROIC0,19%
Net Margin-8,41%
Op. Margin0,55%
Sécurité
Debt / Equity
N/A
Current Ratio3,62
Interest Coverage0,07
Valorisation
P/E Ratio
-12,63
P/B RatioN/A
EV/EBITDA565,16
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,77% | Revenue Growth (3Y) | 4,39% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,29% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,12B | Net Income (TTM) | -262,69M |
| ROE | -313,25% | ROA | -4,41% |
| Gross Margin | 20,64% | Operating Margin | 0,55% |
| Net Margin | -8,41% | Free Cash Flow (TTM) | -294,52M |
| ROIC | 0,19% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3,62 |
| Interest Coverage | 0,07 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -12,63 | P/B Ratio | N/A |
| P/S Ratio | 1,06 | PEG Ratio | -0,39 |
| EV/EBITDA | 565,16 | Dividend Yield | 0,00% |
| Market Cap | 3,32B | Enterprise Value | 9,70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,12B | 2,98B | 2,87B | 2,74B | 2,75B |
| Net Income | -262,69M | -201,94M | -189,01M | -238,43M | -99,29M |
| EPS (Diluted) | -1,11 | -0,89 | -0,84 | -1,25 | -0,54 |
| Gross Profit | 645,02M | 807,43M | 744,71M | 513,94M | 488,58M |
| Operating Income | 17,17M | 46,53M | 18,41M | -42,69M | -216,94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,95B | 6,34B | 5,57B | 5,94B | 6,41B |
| Total Liabilities | 6,00B | 6,12B | 5,17B | 5,35B | 5,71B |
| Shareholders' Equity | -44,75M | 212,48M | 403,66M | 582,61M | 697,40M |
| Total Debt | 6,66B | 5,65B | 4,73B | 4,89B | 5,23B |
| Cash & Equivalents | 279,12M | 308,93M | 277,97M | 398,85M | 347,03M |
| Current Assets | 553,94M | 512,94M | 478,37M | 637,09M | 698,99M |
| Current Liabilities | 153,23M | 579,76M | 600,12M | 641,21M | 631,95M |